Completed NA INTERVENTIONAL 2-arm NCT02603471

Cell Phone Technology Targeting ART and Naltrexone Adherence and Alcohol Use (ALCTXT)

Sponsor: University of California, Los Angeles

Conditions Alcohol Dependence HIV Infections

Interventions Informational group Text Messaging CBT (TXT-CBT)

Updated 7 times since 2017 Last updated: Apr 22, 2022 Started: Jul 31, 2014 Primary completion: Dec 31, 2016 Completion: Dec 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02603471, this NA trial focuses on Alcohol Dependence and HIV Infections and remains completed. Sponsored by University of California, Los Angeles, it has been updated 7 times since 2014, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
May 2022 — Jul 2024 [monthly]

Completed NA

Status: Unknown Status → Completed
Jan 2021 — May 2022 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA

▶ Show 2 earlier versions

Feb 2018 — Jun 2018 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2017 — Feb 2018 [monthly]

Recruiting NA

First recorded

Jul 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of California, Los Angeles

Data source: University of California, Los Angeles

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Los Angeles, United States